Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care |
| Investment focus | Aktien, Welt, Gesundheitswesen, Sozial/Nachhaltig |
| Fund size | EUR 243 m |
| Total expense ratio | 0,18% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Investment approach | Long-only |
| Sustainability | Ja |
| Fund currency | EUR |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 13,07% |
| Inception/ Listing Date | 20. September 2022 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Irland |
| Fund Provider | Amundi ETF |
| Fund Structure | Company With Variable Capital (SICAV) |
| UCITS compliance | Yes |
| Administrator | HSBC Securities Services (Ireland) DAC |
| Investment Advisor | |
| Custodian Bank | HSBC Bank PLC |
| Revision Company | - |
| Fiscal Year End | 31. Dezember |
| Swiss representative | NO |
| Swiss paying agent | NO |
| Germany | 30% Teilfreistellung |
| Switzerland | ESTV Reporting |
| Austria | Meldefonds |
| UK | UK Reporting |
| Italy | 26,0% |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | Yes |
| Securities lending counterparty |
| Eli Lilly & Co. | 11,05% |
| AbbVie, Inc. | 6,91% |
| Merck & Co., Inc. | 4,98% |
| AstraZeneca PLC | 4,74% |
| UnitedHealth Group | 4,72% |
| Novartis AG | 4,28% |
| Roche Holding AG | 4,24% |
| Amgen, Inc. | 3,31% |
| Thermo Fisher Scientific | 3,27% |
| Gilead Sciences, Inc. | 2,87% |
| Gesundheitswesen | 91,78% |
| Nicht-Basiskonsumgüter | 0,95% |
| Sonstige | 7,28% |
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
| 0,00 € | 0,00 € | Zum Angebot* | |
| 0,00 € | 0,00 € | Zum Angebot** | |
| 0,00 € | 0,00 € | Zum Angebot* | |
| 0,00 € | 0,00 € | Zum Angebot* | |
| 0,00 € | 0,00 € | Zum Angebot* |
| YTD | -4.24% |
| 1 month | +4.44% |
| 3 months | -5.83% |
| 6 months | -5.91% |
| 1 year | +6.70% |
| 3 years | +7.55% |
| 5 years | - |
| Since inception (MAX) | +8.30% |
| 2025 | +0.35% |
| 2024 | +7.74% |
| 2023 | +2.15% |
| 2022 | - |
| Volatility 1 year | 13.08% |
| Volatility 3 years | 12.89% |
| Volatility 5 years | - |
| Return per risk 1 year | 0.51 |
| Return per risk 3 years | 0.19 |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -12.07% |
| Maximum drawdown 3 years | -22.59% |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -22.59% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | WELS | - - | - - | - |
| Euronext Paris | EUR | GLHL | GLHL FP IWELS | GLHL.PA IWELSEURINAV=SOLA | BNP Paribas Arbitrage |
| SIX Swiss Exchange | USD | WEL9 | WEL9 SW WEL9USIV | WEL9.S IWEL9USDINAV=SOLA | BNP Paribas Arbitrage |
| XETRA | USD | WEL9 | WEL9 GY WEL9USIV | WELSGUSD.DE IWEL9USDINAV=SOLA | BNP Paribas Arbitrage |
| XETRA | EUR | WELS | WELS GY IWELS | WELSG.DE IWELSEURINAV=SOLA | BNP Paribas Arbitrage |
| Fondsname | Fondsgröße in Mio. € (AuM) | TER p.a. | Ausschüttung | Replikation |
|---|---|---|---|---|
| Amundi S&P Global Health Care ESG UCITS ETF DR EUR (D) | 122 | 0,18% p.a. | Ausschüttend | Vollständig |